NSB Price sensitive 1 Oct 2026, 9:38 AM

Leading CRO Appointed for Phase 2 Crohn's Trial

Neuroscientific Biopharmaceuticals Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in